Announcements
Investor News
BioPorto A/S
BioPorto Advances U.S. Adult Urine NGAL Program with FDA Pre-Submission Request After Positive EPACRA AKI Cut Off Analysis
Tue, 31 Mar 2026 15:43 GMT
BioPorto A/S
BioPorto indsender anmodning om FDA pre‑submission for amerikansk voksenprogram for urin‑NGAL efter positiv EPACRA‑analyse af AKI‑cut‑off
Tue, 31 Mar 2026 15:43 GMT
BioPorto A/S
KDIGO publishes 2026 Clinical Practice Guideline Draft for Acute Kidney Injury and Acute Kidney Disease
Tue, 31 Mar 2026 10:34 GMT
BioPorto A/S
KDIGO offentliggør udkast til klinisk praksis guideline 2026 for akut nyreskade og akut nyresygdom
Tue, 31 Mar 2026 10:34 GMT